4 commercial payer policies list P07.30. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
4 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of P07.30 |
|---|---|---|
| Palivizumab (Synagis) | Feb 15, 2024 | Covered |
| Quantitative EEG (Brain Mapping) | Apr 25, 2023 | Covered |
| T-Wave Alternans | Jul 28, 2023 | Covered |
| Policy | Effective | Status of P07.30 |
|---|---|---|
| Inhaled Nitric Oxide | Jul 1, 2026 | Covered |